These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6487486)

  • 21. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.
    Tzamaloukas AH; Murata GH; Piraino B; Rao P; Bernardini J; Malhotra D; Oreopoulos DG
    Kidney Int; 1998 May; 53(5):1405-11. PubMed ID: 9573559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysis.
    Bailie GR; Waldek S
    J Clin Pharm Ther; 1988 Apr; 13(2):121-4. PubMed ID: 3134365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Sica DA; Comstock T; Harford A; Eshelman F
    Eur J Clin Pharmacol; 1987; 32(6):587-91. PubMed ID: 3653228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental model for pharmacokinetic studies during continuous peritoneal dialysis in the rabbit.
    Traina GL; Celardo A; Arboix M; Bonati M
    J Pharmacol Methods; 1986 Apr; 15(2):133-41. PubMed ID: 3702467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis.
    Pancorbo S; Comty C
    Antimicrob Agents Chemother; 1981 Apr; 19(4):605-7. PubMed ID: 7247382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
    Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
    J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daily clearances with continuous ambulatory peritoneal dialysis and nightly peritoneal dialysis.
    Twardowski ZJ; Nolph KD; Khanna R; Gluck Z; Prowant BF; Ryan LP
    ASAIO Trans; 1986; 32(1):575-80. PubMed ID: 3778773
    [No Abstract]   [Full Text] [Related]  

  • 30. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
    Pancorbo S; Comty C
    Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous ambulatory peritoneal dialysis (CAPD) in children.
    Potter DE; McDaid TK; McHenry K; Mar H
    Trans Am Soc Artif Intern Organs; 1981; 27():64-7. PubMed ID: 7331148
    [No Abstract]   [Full Text] [Related]  

  • 32. Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.
    Ortega O; Gallar P; Carreño A; Gutierrez M; Rodriguez I; Oliet A; Vigil A; Gimenez E
    Am J Nephrol; 2001; 21(3):189-93. PubMed ID: 11423687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications.
    Hodler JE; Galeazzi RL; Frey B; Rudhardt M; Seiler AJ
    Eur J Clin Pharmacol; 1984; 26(5):609-12. PubMed ID: 6468477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobramycin kinetics during continuous ambulatory peritoneal dialysis.
    Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
    Clin Pharmacol Ther; 1983 Jul; 34(1):110-6. PubMed ID: 6861432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis.
    Sica DA; Yonce C; Small R; Cefali E; Harford A; Poynor W
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):59-64. PubMed ID: 2457560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher KT/V urea associated with greater protein catabolic rate and dietary protein intake in children treated with CCPD compared to CAPD. Mid-European Pediatric CPD Study Group (MPCS).
    Schaefer F; Wolf S; Klaus G; Langenbeck D; Mehls O
    Adv Perit Dial; 1994; 10():310-4. PubMed ID: 7999855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myoglobin elimination in end stage kidney disease patients on renal replacement treatment.
    Stefanović V; Bogićević M; Mitić M
    Int J Artif Organs; 1993 Sep; 16(9):659-61. PubMed ID: 8294158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
    Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
    Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.